METHODS FOR IMPROVING EXPRESSION OF TRANSFECTED IMMUNOGLOBULIN GENES

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$50,000.00
Award Year:
1987
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
7106
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Integrated Chemical Sensors
44 Mechanic St, Newton, MA, 02164
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
MARVIN B HENDRICKS PHD
(617) 875-1336
Business Contact:
() -
Research Institution:
n/a
Abstract
THE AIM OF THIS RESEARCH PROPOSAL IS TO DEVELOP METHODS TO IMPROVE THE EXPRESSION OF TRANSFECTED IMMUNOGLOBULIN (IG) GENES. THE LONG-TERM GOAL IS TO IMPROVE THE YIELD OF GENETICALLY ENGINEERED ANTIBODIES OF THERAPEUTIC VALUE. PHASE I WILL INVESTIGATE TWO APPROACHES TO INCREASE EXPRESSION. ONE APPROACH IS TO IDENTIFY HOST MYELOMA CELLS THAT ARE MORE ACTIVE IN EXPRESSING TRANSFECTED IG GENES; THE OTHER APPROACH IS TO DEVELOP SCHEMES TO INCREASE THE NUMBER OF GENE COPIES THAT ARE EXPRESSED. PHASE II RESEARCH WILL IMPLEMENT THE FINDINGS OF PHASE I TO FORMULATE A METHODOLOGY AND SET UP EXPERIMENTS TO EXPRESS HIGH LEVELS OF GENETICALLY MODIFIED ANTIBODIES. THE RESEARCH THAT IS PROPOSED HERE COULD LEAD TO THE PRODUCTION OF GENETICALLY MODIFIED ANTIBODIES IN YIELDS COMPARABLE TO THAT OF HIGHLY PRODUCTIVE MYELOMA OR HYBRIDOMA CELL LINES. THIS WOULD THEN MAKE THE PRODUCTION OF GENETICALLY ENGINEERED ANTIBODIES A COMMERCIALLY FEASIBLE PROCESS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government